Wilms tumor, a rare kidney cancer primarily affecting children, presents a unique challenge in cancer research. Researchers are exploring various aspects to understand its etiology and improve treatment outcomes. Genomic studies have identified mutations in genes like WT1 and CTNNB1, shedding light on the tumor's genetic basis. Advances in imaging technologies aid in early detection, crucial for successful treatment. Additionally, targeted therapies, such as those inhibiting angiogenesis or exploiting specific molecular pathways, offer promising avenues. Immunotherapy, harnessing the body's immune system to fight cancer cells, is also being investigated. Collaborative efforts between oncologists, geneticists, and immunologists are crucial in unraveling Wilms tumor's complexities and devising effective therapeutic strategies. Through interdisciplinary research, the aim is to enhance survival rates and quality of life for children battling this challenging malignancy.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States